CITADEL ADVISORS LLC

Position in CNSY — Cerenome, Inc.

CIK 1423053 MIAMI, FL

Position in CNSY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$111,858

+$17,054 QoQ

Shares Held

25,597

-86.2% QoQ

Ownership

0.337%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 22 holders

Holding Since

Sep 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,839,618 across 436 Biotechnology names. CNSY ranks #350 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ONC	BeOne Medicines Ltd.	1,425,517	$406,229,578
2	BBIO	BridgeBio Pharma, Inc.	3,760,028	$280,046,885
3	INSM	INSMED Inc	2,556,973	$272,624,460
4	MDGL	Madrigal Pharmaceuticals, Inc.	507,233	$272,358,759
5	VRTX	Vertex Pharmaceuticals Inc / Ma	510,430	$253,545,893
6	JAZZ	Jazz Pharmaceuticals plc	1,006,676	$242,578,715
7	MANE	Veradermics, Inc	1,877,775	$230,853,658
8	ROIV	Roivant Sciences Ltd.	5,576,261	$197,343,876

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$111,858	25,597	-86.2%	Shares	Defined	2026-08-14
2025-12-31	$94,804	185,056	+912.2%	Shares	Defined	2026-02-17
2024-06-30	$26,876	18,283	+70.7%	Shares	Defined	2024-08-14
2024-03-31	$19,329	10,709	-36.4%	Shares	Defined	2024-05-15
2023-12-31	$29,469	16,839	+0.4%	Shares	Defined	2024-02-14
2022-09-30	$7,463	16,772	-79.8%	Shares	Defined	2022-11-14
2021-12-31	$87,306	83,149	+91.0%	Shares	Defined	2022-02-14
2021-06-30	$111,434	43,529	+249.7%	Shares	Defined	2021-08-16
2020-12-31	$25,142	12,447	-45.1%	Shares	Defined	2021-02-16
2020-09-30	$58,007	22,659	—	Shares	Defined	2020-11-16
No filing history on record for this holder in this stock.